Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.

Tytuł:
A Founder Effect Led Early SARS-CoV-2 Transmission in Spain.
Autorzy:
Díez-Fuertes F; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain .; IDIBAPS-Hospital Clinic de Barcelona, Barcelona, Spain.
Iglesias-Caballero M; Respiratory Virus and Influenza Unit, National Center of Microbiology, National Influenza Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
García-Pérez J; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Monzón S; Bioinformatics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Jiménez P; Genomics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Varona S; Bioinformatics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Cuesta I; Bioinformatics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Zaballos Á; Genomics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Jiménez M; Genomics Unit, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Checa L; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Pozo F; Respiratory Virus and Influenza Unit, National Center of Microbiology, National Influenza Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Pérez-Olmeda M; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Thomson MM; HIV Biology and Variability Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Alcamí J; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.; IDIBAPS-Hospital Clinic de Barcelona, Barcelona, Spain.
Casas I; Respiratory Virus and Influenza Unit, National Center of Microbiology, National Influenza Center, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain .
Źródło:
Journal of virology [J Virol] 2021 Jan 13; Vol. 95 (3). Date of Electronic Publication: 2021 Jan 13 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
Język:
English
Imprint Name(s):
Publication: Washington Dc : American Society For Microbiology
Original Publication: Baltimore, American Society for Microbiology.
MeSH Terms:
Founder Effect*
COVID-19/*transmission
COVID-19/*virology
SARS-CoV-2/*genetics
COVID-19/epidemiology ; Genetic Fitness ; Genetic Variation ; Genome, Viral/genetics ; Humans ; Phylogeny ; Phylogeography ; Prevalence ; SARS-CoV-2/classification ; Spain/epidemiology ; Spike Glycoprotein, Coronavirus/genetics
References:
Nature. 2020 Mar;579(7798):270-273. (PMID: 32015507)
J Med Virol. 2007 Feb;79(2):127-37. (PMID: 17177310)
Nat Med. 2020 Apr;26(4):450-452. (PMID: 32284615)
Cell. 2020 Aug 20;182(4):812-827.e19. (PMID: 32697968)
Bioinformatics. 2018 Sep 1;34(17):i884-i890. (PMID: 30423086)
Swiss Med Wkly. 2020 Feb 27;150(9-10):. (PMID: 32227799)
Nat Methods. 2012 Mar 04;9(4):357-9. (PMID: 22388286)
Fly (Austin). 2012 Apr-Jun;6(2):80-92. (PMID: 22728672)
Nat Microbiol. 2020 Apr;5(4):536-544. (PMID: 32123347)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Glob Chall. 2017 Jan 10;1(1):33-46. (PMID: 31565258)
PLoS Comput Biol. 2009 Sep;5(9):e1000520. (PMID: 19779555)
mBio. 2014 Feb 18;5(1):. (PMID: 24549846)
Virus Evol. 2018 Jun 08;4(1):vey016. (PMID: 29942656)
Syst Biol. 2018 Sep 1;67(5):901-904. (PMID: 29718447)
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66. (PMID: 12136088)
Bioinformatics. 2014 Nov 15;30(22):3276-8. (PMID: 25095880)
BMC Evol Biol. 2004 Jun 28;4:21. (PMID: 15222897)
Retrovirology. 2015 Jun 18;12:50. (PMID: 26081316)
Nat Biotechnol. 2020 Mar;38(3):276-278. (PMID: 32055031)
Mol Biol Evol. 2016 Aug;33(8):2167-9. (PMID: 27189542)
Front Genet. 2012 Mar 15;3:35. (PMID: 22435069)
Emerg Microbes Infect. 2019;8(1):1054-1065. (PMID: 31335277)
Nature. 2020 Jul;583(7815):282-285. (PMID: 32218527)
Bioinformatics. 2018 Dec 1;34(23):4121-4123. (PMID: 29790939)
Bioinformatics. 2016 Oct 1;32(19):3047-8. (PMID: 27312411)
PLoS Pathog. 2020 May 14;16(5):e1008421. (PMID: 32407364)
Lancet Infect Dis. 2020 Aug;20(8):920-928. (PMID: 32422201)
PLoS One. 2010 Mar 10;5(3):e9490. (PMID: 20224823)
Bioinformatics. 2009 Sep 1;25(17):2283-5. (PMID: 19542151)
Virus Evol. 2016 Apr 09;2(1):vew007. (PMID: 27774300)
Nat Commun. 2020 Mar 27;11(1):1620. (PMID: 32221306)
Curr Biol. 2020 Jun 8;30(11):2196-2203.e3. (PMID: 32416074)
Bioinformatics. 2009 Aug 15;25(16):2078-9. (PMID: 19505943)
Genome Biol. 2019 Jan 8;20(1):8. (PMID: 30621750)
Bioinformatics. 2010 Mar 15;26(6):841-2. (PMID: 20110278)
Genome Biol. 2019 Nov 28;20(1):257. (PMID: 31779668)
Nat Microbiol. 2020 Nov;5(11):1403-1407. (PMID: 32669681)
Nature. 2020 Mar;579(7798):265-269. (PMID: 32015508)
Contributed Indexing:
Keywords: COVID-19; Europe; SARS-CoV-2; Spain; phylodynamics; phylogeography
Substance Nomenclature:
0 (Spike Glycoprotein, Coronavirus)
0 (spike protein, SARS-CoV-2)
Entry Date(s):
Date Created: 20201031 Date Completed: 20210122 Latest Revision: 20210312
Update Code:
20240105
PubMed Central ID:
PMC7925114
DOI:
10.1128/JVI.01583-20
PMID:
33127745
Czasopismo naukowe
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) whole-genome analysis has identified five large clades worldwide which emerged in 2019 (19A and 19B) and in 2020 (20A, 20B, and 20C). This study aimed to analyze the diffusion of SARS-CoV-2 in Spain using maximum-likelihood phylogenetic and Bayesian phylodynamic analyses. The most recent common ancestor (MRCA) of the SARS-CoV-2 pandemic was estimated to have emerged in Wuhan, China, around 24 November 2019. Phylogenetic analyses of the first 12,511 SARS-CoV-2 whole-genome sequences obtained worldwide, including 290 from 11 different regions of Spain, revealed 62 independent introductions of the virus in the country. Most sequences from Spain were distributed in clades characterized by a D614G substitution in the S gene (20A, 20B, and 20C) and an L84S substitution in ORF8 (19B) with 163 and 118 sequences, respectively, with the remaining sequences branching in 19A. A total of 110 (38%) sequences from Spain grouped in four different monophyletic clusters of clade 20A (20A-Sp1 and 20A-Sp2) and 19B clade (19B-Sp1 and 19B-Sp2) along with sequences from 29 countries worldwide. The MRCAs of clusters 19A-Sp1, 20A-Sp1, 19A-Sp2, and 20A-Sp2 were estimated to have occurred in Spain around 21 and 29 January and 6 and 17 February 2020, respectively. The prevalence of clade 19B in Spain (40%) was by far higher than in any other European country during the first weeks of the epidemic, probably as a result of a founder effect. However, this variant was replaced by G614-bearing viruses in April. In vitro assays showed an enhanced infectivity of pseudotyped virions displaying the G614 substitution compared with those having D614, suggesting a fitness advantage of D614G. IMPORTANCE Multiple SARS-CoV-2 introductions have been detected in Spain, and at least four resulted in the emergence of locally transmitted clusters that originated not later than mid-February, with further dissemination to many other countries around the world, and a few weeks before the explosion of COVID-19 cases detected in Spain during the first week of March. The majority of the earliest variants detected in Spain branched in the clade 19B (D614 viruses), which was the most prevalent clade during the first weeks of March, pointing to a founder effect. However, from mid-March to June 2020, G614-bearing viruses (clades 20A, 20B, and 20C) overcame D614 variants in Spain, probably as a consequence of an evolutionary advantage of this substitution in the spike protein. A higher infectivity of G614-bearing viruses than D614 variants was detected, suggesting that this substitution in SARS-CoV-2 spike protein could be behind the variant shift observed in Spain.
(Copyright © 2021 Díez-Fuertes et al.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies